• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于纵向数据和事件时间联合分析的共享参数模型。

Shared parameter models for the joint analysis of longitudinal data and event times.

作者信息

Vonesh Edward F, Greene Tom, Schluchter Mark D

机构信息

Baxter Healthcare Corporation, Round Lake, IL 60073, USA.

出版信息

Stat Med. 2006 Jan 15;25(1):143-63. doi: 10.1002/sim.2249.

DOI:10.1002/sim.2249
PMID:16025541
Abstract

Longitudinal studies often gather joint information on time to some event (survival analysis, time to dropout) and serial outcome measures (repeated measures, growth curves). Depending on the purpose of the study, one may wish to estimate and compare serial trends over time while accounting for possibly non-ignorable dropout or one may wish to investigate any associations that may exist between the event time of interest and various longitudinal trends. In this paper, we consider a class of random-effects models known as shared parameter models that are particularly useful for jointly analysing such data; namely repeated measurements and event time data. Specific attention will be given to the longitudinal setting where the primary goal is to estimate and compare serial trends over time while adjusting for possible informative censoring due to patient dropout. Parametric and semi-parametric survival models for event times together with generalized linear or non-linear mixed-effects models for repeated measurements are proposed for jointly modelling serial outcome measures and event times. Methods of estimation are based on a generalized non-linear mixed-effects model that may be easily implemented using existing software. This approach allows for flexible modelling of both the distribution of event times and of the relationship of the longitudinal response variable to the event time of interest. The model and methods are illustrated using data from a multi-centre study of the effects of diet and blood pressure control on progression of renal disease, the modification of diet in renal disease study.

摘要

纵向研究通常会收集关于某个事件发生时间(生存分析、失访时间)的联合信息以及系列结局测量指标(重复测量、生长曲线)。根据研究目的,研究者可能希望在考虑可能不可忽略的失访情况下估计和比较随时间的系列趋势,或者希望研究感兴趣的事件时间与各种纵向趋势之间可能存在的关联。在本文中,我们考虑一类称为共享参数模型的随机效应模型,这类模型对于联合分析此类数据特别有用,即重复测量数据和事件时间数据。我们将特别关注纵向研究场景,其主要目标是在调整因患者失访导致的可能信息删失的情况下,估计和比较随时间的系列趋势。本文提出了用于事件时间的参数和半参数生存模型,以及用于重复测量的广义线性或非线性混合效应模型,以联合建模系列结局测量指标和事件时间。估计方法基于一个广义非线性混合效应模型,该模型可使用现有软件轻松实现。这种方法允许对事件时间的分布以及纵向响应变量与感兴趣的事件时间之间的关系进行灵活建模。我们使用来自一项关于饮食和血压控制对肾脏疾病进展影响的多中心研究(肾脏疾病饮食改良研究)的数据来说明该模型和方法。

相似文献

1
Shared parameter models for the joint analysis of longitudinal data and event times.用于纵向数据和事件时间联合分析的共享参数模型。
Stat Med. 2006 Jan 15;25(1):143-63. doi: 10.1002/sim.2249.
2
Conditional mixed models adjusting for non-ignorable drop-out with administrative censoring in longitudinal studies.纵向研究中通过行政删失调整不可忽略的失访的条件混合模型。
Stat Med. 2004 Nov 30;23(22):3489-503. doi: 10.1002/sim.1926.
3
Analysis of change in the presence of informative censoring: application to a longitudinal clinical trial of progressive renal disease.信息删失存在情况的变化分析:在一项进行性肾病纵向临床试验中的应用。
Stat Med. 2001 Apr 15;20(7):989-1007. doi: 10.1002/sim.720.
4
Partly conditional survival models for longitudinal data.纵向数据的部分条件生存模型。
Biometrics. 2005 Jun;61(2):379-91. doi: 10.1111/j.1541-0420.2005.00323.x.
5
Robustness of a parametric model for informatively censored bivariate longitudinal data under misspecification of its distributional assumptions: A simulation study.分布假设设定错误下信息删失双变量纵向数据参数模型的稳健性:一项模拟研究
Stat Med. 2007 Dec 30;26(30):5473-85. doi: 10.1002/sim.3147.
6
Joint modelling of longitudinal measurements and event time data.纵向测量数据与事件时间数据的联合建模
Biostatistics. 2000 Dec;1(4):465-80. doi: 10.1093/biostatistics/1.4.465.
7
A two-part joint model for the analysis of survival and longitudinal binary data with excess zeros.用于分析具有过多零值的生存和纵向二元数据的两部分联合模型。
Biometrics. 2008 Jun;64(2):611-9. doi: 10.1111/j.1541-0420.2007.00894.x. Epub 2007 Aug 28.
8
A comparison of two methods for the estimation of precision with incomplete longitudinal data, jointly modelled with a time-to-event outcome.两种用于估计精度的方法在不完全纵向数据情况下的比较,这些数据与事件发生时间结局联合建模。
Stat Med. 2003 Oct 30;22(20):3161-75. doi: 10.1002/sim.1547.
9
Joint inference for nonlinear mixed-effects models and time to event at the presence of missing data.存在缺失数据时非线性混合效应模型与事件发生时间的联合推断
Biostatistics. 2008 Apr;9(2):308-20. doi: 10.1093/biostatistics/kxm029. Epub 2007 Aug 29.
10
Joint analysis of longitudinal data with informative right censoring.对具有信息性右删失的纵向数据进行联合分析。
Biometrics. 2007 Jun;63(2):363-71. doi: 10.1111/j.1541-0420.2007.00708.x. Epub 2007 Apr 9.

引用本文的文献

1
Semiparametric joint modeling to estimate the treatment effect on a longitudinal surrogate with application to chronic kidney disease trials.用于估计对纵向替代指标治疗效果的半参数联合建模及其在慢性肾脏病试验中的应用。
Biometrics. 2025 Jul 3;81(3). doi: 10.1093/biomtc/ujaf104.
2
Relationship between prostate-specific antigen, alkaline phosphatase levels, and time-to-tumor shrinkage: understanding the progression of prostate cancer in a longitudinal study.前列腺特异性抗原、碱性磷酸酶水平与肿瘤退缩时间的关系:纵向研究中前列腺癌进展的理解。
BMC Urol. 2024 Jul 2;24(1):137. doi: 10.1186/s12894-024-01522-8.
3
Effects of empagliflozin in patients with chronic kidney disease from Japan: exploratory analyses from EMPA-KIDNEY.
恩格列净在日本慢性肾脏病患者中的作用:来自 EMPA-KIDNEY 的探索性分析。
Clin Exp Nephrol. 2024 Jun;28(6):588-595. doi: 10.1007/s10157-024-02489-4. Epub 2024 Apr 20.
4
An Introduction and Practical Guide to Strategies for Analyzing Longitudinal Data in Clinical Trials of Smoking Cessation Treatment: Beyond Dichotomous Point-Prevalence Outcomes.在戒烟治疗的临床试验中分析纵向数据的策略介绍及实用指南:超越二分点现患结局。
Nicotine Tob Res. 2024 Jun 21;26(7):796-805. doi: 10.1093/ntr/ntae005.
5
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.恩格列净对慢性肾脏病进展的影响:来自 empa-kidney 试验的预先指定的次要分析。
Lancet Diabetes Endocrinol. 2024 Jan;12(1):39-50. doi: 10.1016/S2213-8587(23)00321-2. Epub 2023 Dec 4.
6
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure.一项关于肾小球滤过率(GFR)斜率作为肾衰竭替代终点的荟萃分析。
Nat Med. 2023 Jul;29(7):1867-1876. doi: 10.1038/s41591-023-02418-0. Epub 2023 Jun 17.
7
Multimorbid Patterns and Cognitive Performance in the Presence of Informative Dropout Among Community-Dwelling Taiwanese Older Adults.台湾社区居住老年人中存在信息性失访情况下的多病模式与认知表现
Innov Aging. 2023 Feb 8;7(2):igad012. doi: 10.1093/geroni/igad012. eCollection 2023.
8
Long-Term Changes in Estimated Glomerular Filtration Rate in Left Ventricular Assist Device Recipients: A Longitudinal Joint Model Analysis.左心室辅助装置受者估计肾小球滤过率的长期变化:纵向联合模型分析。
J Am Heart Assoc. 2023 Feb 7;12(3):e025993. doi: 10.1161/JAHA.122.025993. Epub 2023 Feb 3.
9
The future of psychopharmacology: a critical appraisal of ongoing phase 2/3 trials, and of some current trends aiming to de-risk trial programmes of novel agents.精神药理学的未来:对正在进行的2/3期试验以及旨在降低新型药物试验项目风险的一些当前趋势的批判性评估。
World Psychiatry. 2023 Feb;22(1):48-74. doi: 10.1002/wps.21056.
10
Empagliflozin in Patients with Chronic Kidney Disease.恩格列净在慢性肾脏病患者中的应用。
N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4.